Skip to content
Disclosery

EXANE DERIVATIVES: EGO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on EGO, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 42,175 EGO shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 42,175 shares
    Change vs previous 13F +41,999 shares

    0.15% of the 13F portfolio, value $269,439.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 176 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $1,973.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 176 shares
    Change vs previous 13F -41,754 shares

    <0.01% of the 13F portfolio, value $1,646.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 41,930 shares
    Change vs previous 13F +2,663 shares

    0.08% of the 13F portfolio, value $324,122.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 39,267 shares
    Change vs previous 13F +3,695 shares

    0.09% of the 13F portfolio, value $383,248.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 35,572 shares
    Change vs previous 13F +5,391 shares

    0.12% of the 13F portfolio, value $383,826.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 30,181 shares
    Change vs previous 13F +831 shares

    0.12% of the 13F portfolio, value $400,505.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 29,350 shares
    Change vs previous 13F not available

    0.1% of the 13F portfolio, value $309,646.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).